Hostname: page-component-6587cd75c8-h2j7s Total loading time: 0 Render date: 2025-04-23T23:39:21.052Z Has data issue: false hasContentIssue false
  • English
  • Français

Diagnosis of underlying mechanisms of diffuse microvascular bleeding allows targeted therapy

Published online by Cambridge University Press:  28 January 2005

D. Fries ,
P. Innerhofer  and
D. Fries
Affiliation:
Department of Anaesthesiology and Critical Care Medicine, Leopold-Franzens University, Innsbruck, Austria
P. Innerhofer
Affiliation:
Department of Anaesthesiology and Critical Care Medicine, Leopold-Franzens University, Innsbruck, Austria
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
European Journal of Anaesthesiology , Volume 21 , Issue 11 , November 2004 , pp. 918 - 919
Copyright
2004 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Menzebach A, Cassens U, Van Aken H, Booke M. Strategies to reduce perioperative blood loss related to non-surgical bleeding. Eur J Anaesthesiol 2003; 20: 764–770.Google Scholar
Henry DA, Moxey AJ, Carless PA, et al. Desmopressin for minimizing perioperative allogenic blood transfusion. Cochrane Database of Systematic Reviews 2001; 2: CD001884.Google Scholar
Porte RJ, Leebeek FW. Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery. Drugs 2002; 62: 2193–2211.Google Scholar
Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360–365.Google Scholar
Mardel SN, Saunders FM, Allen H, et al. Reduced clot quality of clot formation with gelatin based plasma substitutes. Br J Anaesth 1998; 80: 204–207.Google Scholar
Gerlach R, Tölle F, Raabe A, et al. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased FXIII activity. Stroke 2002; 33: 1618–1623.Google Scholar
Warren BL, Eid A, Singer P, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. J Am Med Assoc 2001; 286: 1869–1878.Google Scholar